Food and Drug Administration, USA
6+ months Nontransferable vouchers Enhanced presubmission requests to facilitate expedited rolling review Multidisciplinary tumor board-style discussion between review team and senior agency leadership The CNPV pilot is consistent with the FDAs mission and maintains the FDAs established safety and effectiveness approval standards, scientific rigor and regulatory compliance requirements
severe impairment, n = 5) and the hepatic impairment study included 32 participants (normal function, n = 14
Patients report similar efficacy and side effect profiles, with the added benefit of dose flexibility and lower cost
Foundayo (Orforglipron) Foundayo, the newfound gem in the GLP-1 category, offers flexibility with its once-daily pill format
That finding is notable because tirzepatide achieved larger and faster weight reductions while also showing lower documented rates of several adverse events